UroGen Pharma Ltd (URGN)
14.30
+0.04
(+0.28%)
USD |
NASDAQ |
May 03, 16:00
14.29
-0.01
(-0.07%)
After-Hours: 20:00
UroGen Pharma 1 Year Total Returns (Daily): 11.72% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 11.72% |
| May 02, 2024 | 9.19% |
| May 01, 2024 | 0.77% |
| April 30, 2024 | 19.24% |
| April 29, 2024 | 21.14% |
| April 26, 2024 | 15.51% |
| April 25, 2024 | 19.04% |
| April 24, 2024 | 23.03% |
| April 23, 2024 | 44.72% |
| April 22, 2024 | 43.13% |
| April 19, 2024 | 34.61% |
| April 18, 2024 | 49.63% |
| April 17, 2024 | 48.33% |
| April 16, 2024 | 50.47% |
| April 15, 2024 | 56.80% |
| April 12, 2024 | 64.67% |
| April 11, 2024 | 42.78% |
| April 10, 2024 | 37.91% |
| April 09, 2024 | 51.93% |
| April 08, 2024 | 50.11% |
| April 05, 2024 | 55.43% |
| April 04, 2024 | 52.23% |
| April 03, 2024 | 40.10% |
| April 02, 2024 | 52.49% |
| April 01, 2024 | 53.68% |
| Date | Value |
|---|---|
| March 28, 2024 | 87.27% |
| March 27, 2024 | 82.89% |
| March 26, 2024 | 80.81% |
| March 25, 2024 | 98.57% |
| March 22, 2024 | 92.90% |
| March 21, 2024 | 70.74% |
| March 20, 2024 | 76.00% |
| March 19, 2024 | 76.71% |
| March 18, 2024 | 70.59% |
| March 15, 2024 | 50.16% |
| March 14, 2024 | 43.01% |
| March 13, 2024 | 84.87% |
| March 12, 2024 | 89.06% |
| March 11, 2024 | 83.48% |
| March 08, 2024 | 72.48% |
| March 07, 2024 | 76.59% |
| March 06, 2024 | 78.36% |
| March 05, 2024 | 74.85% |
| March 04, 2024 | 78.84% |
| March 01, 2024 | 67.64% |
| February 29, 2024 | 77.96% |
| February 28, 2024 | 76.41% |
| February 27, 2024 | 83.51% |
| February 26, 2024 | 85.35% |
| February 23, 2024 | 64.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-75.16%
Minimum
Feb 18 2022
177.1%
Maximum
Jul 28 2023
-10.30%
Average
-28.51%
Median
Sep 20 2019
1 Year Total Returns (Daily) Benchmarks
| Agenus Inc | -56.14% |
| Exelixis Inc | 14.00% |
| Geron Corp | 47.19% |
| Protalix BioTherapeutics Inc | -63.81% |
| InfuSystems Holdings Inc | -14.06% |